These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17426487)

  • 41. Modulation of amyloid-beta-induced and age-associated changes in rat hippocampus by eicosapentaenoic acid.
    Minogue AM; Lynch AM; Loane DJ; Herron CE; Lynch MA
    J Neurochem; 2007 Nov; 103(3):914-26. PubMed ID: 17711425
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of JWB1-84-1 on memory-related task performance by amyloid Abeta transgenic mice and by young and aged monkeys.
    Sood A; Warren Beach J; Webster SJ; Terry AV; Buccafusco JJ
    Neuropharmacology; 2007 Oct; 53(5):588-600. PubMed ID: 17698153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationally designed dehydroalanine (DeltaAla)-containing peptides inhibit amyloid-beta (Abeta) peptide aggregation.
    Rangachari V; Davey ZS; Healy B; Moore BD; Sonoda LK; Cusack B; Maharvi GM; Fauq AH; Rosenberry TL
    Biopolymers; 2009 Jun; 91(6):456-65. PubMed ID: 19189374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retro-enantio N-methylated peptides as beta-amyloid aggregation inhibitors.
    Grillo-Bosch D; Carulla N; Cruz M; Sánchez L; Pujol-Pina R; Madurga S; Rabanal F; Giralt E
    ChemMedChem; 2009 Sep; 4(9):1488-94. PubMed ID: 19591190
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Altered expression of Abeta metabolism-associated molecules from D-galactose/AlCl(3) induced mouse brain.
    Luo Y; Niu F; Sun Z; Cao W; Zhang X; Guan D; Lv Z; Zhang B; Xu Y
    Mech Ageing Dev; 2009 Apr; 130(4):248-52. PubMed ID: 19150622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.
    Pisalyaput K; Tenner AJ
    J Neurochem; 2008 Feb; 104(3):696-707. PubMed ID: 17986223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different protection of K252a and N-acetyl-L-cysteine against amyloid-beta peptide-induced cortical neuron apoptosis involving inhibition of MLK3-MKK7-JNK3 signal cascades.
    Xu Y; Hou XY; Liu Y; Zong YY
    J Neurosci Res; 2009 Mar; 87(4):918-27. PubMed ID: 18951497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. L-prolyl-L-arginyl-glycineamide induces memory enhancement in chicks.
    Davis JL; Pico RM; Cherkin A
    Peptides; 1983; 4(4):401-4. PubMed ID: 6647114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain power.
    Pujol G
    Surviv News (Atlanta Ga); 2002 Jul; ():9. PubMed ID: 12238477
    [No Abstract]   [Full Text] [Related]  

  • 53. Complexation-induced translational isomerism: shuttling through stepwise competitive binding.
    Marlin DS; González Cabrera D; Leigh DA; Slawin AM
    Angew Chem Int Ed Engl; 2005 Dec; 45(1):77-83. PubMed ID: 16311993
    [No Abstract]   [Full Text] [Related]  

  • 54. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease.
    Khavinson V; Ilina A; Kraskovskaya N; Linkova N; Kolchina N; Mironova E; Erofeev A; Petukhov M
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34071923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liposomal Carrier Conjugated to APP-Derived Peptide for Brain Cancer Treatment.
    Gabay M; Weizman A; Zeineh N; Kahana M; Obeid F; Allon N; Gavish M
    Cell Mol Neurobiol; 2021 Jul; 41(5):1019-1029. PubMed ID: 33025416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Tripeptide RER Mimics Secreted Amyloid Precursor Protein-Alpha in Upregulating LTP.
    Morrissey JA; Bigus E; Necarsulmer JC; Srinivasan V; Peppercorn K; O'Leary DJ; Mockett BG; Tate WP; Hughes SM; Parfitt KD; Abraham WC
    Front Cell Neurosci; 2019; 13():459. PubMed ID: 31680870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reflections on glycogen and β-amyloid: why does glycogenolytic β2-adrenoceptor stimulation not rescue memory after β-amyloid?
    Gibbs M
    Metab Brain Dis; 2015 Feb; 30(1):345-52. PubMed ID: 24810634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The chick as a model for the study of the cellular mechanisms and potential therapies for Alzheimer's disease.
    Mileusnic R; Rose S
    Int J Alzheimers Dis; 2010 Jul; 2010():. PubMed ID: 20721285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection against Abeta-induced memory loss by tripeptide D-Arg-L-Glu-L-Arg.
    Mileusnic R; Lancashire C; Clark J; Rose SP
    Behav Pharmacol; 2007 May; 18(3):231-8. PubMed ID: 17426487
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.